LESIEUR CRISTAL (LESIEUR-CRISTAL)
Casablanca Stock Exchange · Morocco · prices in MAD · close of 21 Oct 2026
Key indicators
| Last close | MAD 275.00 |
|---|---|
| 52-week range | 275.00 – 425.00 |
| Return, 1 month / 3 months | −10.7% / −10.1% |
| Return, 1 year / 3 years | −8.3% / +1.1% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 49.4% |
| Worst drawdown (1 year) | -35.3% |
| Average daily value traded | 0.02M MAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lesieur Cristal is a Moroccan food company that makes edible oils, table olives and condiments. Its cooking and table oils are sold under brands such as Lesieur and Cristal, while its olives and sauces reach households through grocery shops and supermarkets across Morocco. The company also produces products for food service and industrial customers, and it is based in Casablanca, where its operations are centred on processing agricultural raw materials into packaged foods for everyday use.
LESIEUR CRISTAL trades under the code LESIEUR-CRISTAL on the Casablanca Stock Exchange in Morocco, with its price quoted in Moroccan dirhams (MAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
LESIEUR CRISTAL (LESIEUR-CRISTAL) trades on the Casablanca Stock Exchange in Morocco. It last closed at MAD 275.00 on 21 October 2026.
Its price-based Market X-Ray is 26 out of 100 (a weak price profile), ranking 64 of 73 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.3% and over the last three months it fell 10.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Casablanca Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 19 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.9% | ||
| From 52-week high | -35.3% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.1% | ||
| 6-month return | -30.9% | ||
| 12-month return, skipping the last month | 2.7% | ||
| Stability (higher is calmer) | 20 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 49.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.3% | ||
| Liquidity | 23 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M MAD | ||
| Zero-volume days | 8.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.9% |
|---|---|
| 1 month | −10.7% |
| 3 months | −10.1% |
| 6 months | −30.9% |
| 1 year | −8.3% |
| 3 years | +1.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 302.19 / 343.47 |
|---|---|
| Golden / death cross (60 days) | Death, 54 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.46 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Casablanca Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.